Fig. 3

Kaplan-Meier curves assessing cardiovascular and cerebrovascular events in No SLD and MASLD cohorts. (A) Cardiovascular events in the No SLD cohort. (B) Cerebrovascular events in the No SLD cohort. (C) Cardiovascular events in the MASLD cohort. (D) Cerebrovascular events in the MASLD cohort. SLD, steatotic liver disease; MASLD, metabolic dysfunction-associated steatotic liver disease.